期刊文献+

磺脲类降糖药对心血管系统的影响 被引量:1

下载PDF
导出
摘要 磺脲类药物是治疗2型糖尿病的常用药物,近年来有许多临床研究显示其对心血管系统可能有不良影响。如:接受磺脲类药物治疗者更多倾向于发生心肌梗死前心绞痛,其发生心肌梗死时心肌酶谱的增高幅度小于其他患者。磺脲类药物治疗对心肌功能有不良影响,但其对心血管事件预后的影响,不同的研究结论不尽相同。对有心血管疾病的糖尿病患者,治疗应慎用磺脲类药物。
作者 桂明辉 宁光
出处 《国外医学(内分泌学分册)》 2004年第3期199-201,共3页 Foreign Medical Sciences(Section of Endocrinology)
  • 相关文献

参考文献18

  • 1Aronow WS, Ahn C. Incidence of new coronary events in older persons with diabetes mellitus and prior myocardial infarction treated with sulfonylureas, insulin, metformin, and diet alone. Am J Cardiol, 2001,88:556-557.
  • 2Jimenez-Navarro M, Gomez-Doblas JJ, Hernandez-Garcia JM, et al. Docs angina pectoris the week before protect against first acute myocardial infarction in patients with diabetes mellitus? Am J Cardio1,2002,90:160-162.
  • 3Garratt KN, Brady PA, Hassinger NL, et al. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol, 1999,33:119-124.
  • 4del Valle HF, Lascano EC, Negroni JA, et al. Glibenclamide effects on reperfusion-induced malignant arrhythmias and left ventricular mechanical recovery from stunning in conscious sheep. Cardiovasc Res,2001,50:474-485.
  • 5Riddle MC. Editorial: sulfonylureas differ in effects on ischemic preconditioning-is it time to retire glyburide? J Clin Endocrinol Metab,2003,88: 528-530.
  • 6Halkin A, Roth A, Jonas M, et al. Suffonylureas are not associated with increased mortality in diabetics treated with thrombolysis for acute myocardial infarction. J Thromb Thrombolysis, 2001,12:177 - 184.
  • 7Gustsfsson I, Hildebrandt P, Seibaek M, et al. Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. Eur Heart J,2000,21:1937-1943.
  • 8Brady PA, AI-Suwaidi J, Kopecky SL. Sulfonylureas and mortality in diabetic patients after myocardial infarction. Circulation, 1998,97: 709-710.
  • 9Moreno R, Garcia E, Zamorano J, et al. Acute myocardial infarction in diabetic patients. Are we actually doing bad? Eur Heart J,2001,22:1359-1361.
  • 10Lee TM, Chou TF. Impairment of myocardial protection in type 2 diabetic patients. J Clin Endocrinol Metab, 2003,88: 531-537.

同被引文献23

  • 1杨文英.磺脲类药物应用专家共识[J].国外医学(内分泌学分册),2004,24(4):255-259. 被引量:75
  • 2Fisman E Z,Tenenbaum A,Boyko V,et al.Oral antidiabetic treatment in patient with coronary disease:time-related increased mortality on com-bined glyburid/metformin therapy over a 7.7 year followup[J].Clin Cardiol,2001,24:151-158.
  • 3Bell DSH.A comparison of agents used to manage type 2 diabetes mellitus-Need for reappraisal of traditional approaches[J].Treat Endocrinol,2004,3:67-76.
  • 4Ovalle F,Bell D S H.Clinical evidence of thazolidinedione-induced improvement of pancreatic β-cell function in patient with type 2 diabetes mellitus[J].Diabetes Obes Metab,2002,4:56-59.
  • 5Stevens R J, Coleman R L, Adler AI,et al.Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66[J].Diabetes Care,2004,27:201-207.
  • 6Stratton I M,Adler A I,Neil H A W,et al.Association of glycaemia with macrovascular and micravascular complications of type 2 diabetes (UKPDS 35):Prospective observations study[J].BMJ,2000,321:405-412.
  • 7Khaw K T,Wareham N,Luben R,et al.Glycates haemoglobin,diabetes,and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition(EPIC-Norfolk)[J].BMJ,2001,322:15-18.
  • 8ACE guidelines:American College of Endocrinology consensus statement on guidelines for glycemia control[J].Endocr Pract,2002,8(suppl 1):6-11.
  • 9Fonseca V,Rosenstock J,Patwardhan R,et al.Effect of metformin and rosiglitazone combination therapy of in patient with type 2 diabetes mellitus:A randomized controlled trial[J].JAMA,2000,283:1695-1702.
  • 10Hsueh W A,Lyon C J,Quinones M J.Insulin resistance and the endothelium[J].Am J Med,2004,117:109-117.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部